Awareness of anti-HCV immunological status among individuals born between 1969 and 1989 participating in anti-HCV screening [0.03%]
1969至1989年间出生者参与抗HCV筛查后知悉自身抗HCV免疫状态的情况
Massimo De Paschale,Stefano Rusconi,Sergio Finazzi et al.
Massimo De Paschale et al.
The effect of remdesivir and nirmatrelvir/ritonavir on mortality in patients hospitalized with COVID-19 during the Omicron era - an emulated target trial [0.03%]
仿真实验性目标试验评估在奥密克戎疫情期间住院的新冠肺炎患者使用瑞德西韦和奈玛特韦/利托那韦对死亡率的影响
John Karlsson Valik,Pontus Hedberg,Piotr Nowak et al.
John Karlsson Valik et al.
Objectives: Despite widespread population immunity, SARS-CoV-2 infection remains a common cause of hospitalization. While antiviral treatments have shown efficacy in clinical trials, often in outpatient settings, emerging...
European pilot interlaboratory comparison study on mpox virus whole genome sequencing [0.03%]
欧洲麻风病病毒全基因组测序的室间比对研究
Jonas Fuchs,Claire Bertelli,Trestan Pillonel et al.
Jonas Fuchs et al.
Objectives: Since 2022, distinct mpox virus (MPXV) clades are spreading across different geographic regions causing a challenging epidemiological situation. Whole genome sequencing (WGS) proved to be instrumental for pati...
Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multi-center, randomized, double-blind, placebo-controlled, phase 3 clinical trial [0.03%]
国产带状疱疹减毒活疫苗在≥40岁中国健康成人中Ⅲ期临床研究：有效性和安全性
Shenyu Wang,Pengfei Jin,Yaru Quan et al.
Shenyu Wang et al.
Objectives: To evaluate the efficacy and safety of a live-attenuated gelatin-free herpes zoster (HZ) vaccine in adults ≥40 years. Methods: ...
Max W Adelman,Stefano Casarin,Cesar A Arias et al.
Max W Adelman et al.
Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients-Promise, Pitfalls, and Path Forward [0.03%]
移植和血液病患者血浆微生物细胞无DNA测序-前景、陷阱及未来方向
Carlos A Gomez,Sias J Scherger,Anum Abbas et al.
Carlos A Gomez et al.
High rates of acquired resistance to fluoroquinolones, bedaquiline and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of Moldova [0.03%]
摩尔多瓦耐药结核病患者对氟喹诺酮类、贝达奎林和利奈唑胺的获得性耐药率较高
Dumitru Chesov,Maja Reimann,Tishya Mukherjee et al.
Dumitru Chesov et al.
Objectives: Mycobacterium tuberculosis with rifampicin resistance rank among the four critical antimicrobial-resistant pathogens needing priority attention as identified by the World Health Organization (WHO) in 2024. Our...
Disseminated Fusarium solani Complex Infection with Ocular Involvement in a Leukemia Patient [0.03%]
一名白血病患者的系统性Fusarium solani复合体感染并累及眼部
Guangyu Sun,Yongqin Wu,Baolin Tang et al.
Guangyu Sun et al.
Efficacy of influenza vaccines and its relationship with immunological surrogate endpoints: a systematic review and meta-analysis of RCT [0.03%]
流感疫苗的效果及其与免疫替代终点的关系：随机对照试验的系统评价和荟萃分析
Handa Ge,Hong Cao,Jiaxin Lv et al.
Handa Ge et al.
Background: Vaccine efficacy may vary due to influenza strain types, their similarity, and vaccine type. The relationship between immunological surrogate endpoints and vaccine efficacy remains unclear, requiring further i...
Defining epidemiological cut-off (ECOFF) values for Brucella melitensis: An European multi-centre study [0.03%]
布鲁氏菌地中海型血清学流行病学临界值(EPICOFF)的界定：一项欧洲多中心研究
Flavia Dematheis,Joseph Papaparaskevas,Erika Matuschek et al.
Flavia Dematheis et al.
Objectives: Brucellosis in humans is mainly caused by B. melitensis and is associated with a risk of chronic infections and relapses. For appropriate patient treatment decisions and outcomes, clinical breakpoints are need...